NTRB vs. TMCI, CLPT, OM, NNOX, NYXH, SMTI, ZIMV, STIM, TCMD, and SNWV
Should you be buying Nutriband stock or one of its competitors? The main competitors of Nutriband include Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Outset Medical (OM), Nano-X Imaging (NNOX), Nyxoah (NYXH), Sanara MedTech (SMTI), ZimVie (ZIMV), Neuronetics (STIM), Tactile Systems Technology (TCMD), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry.
Nutriband vs. Its Competitors
Treace Medical Concepts (NASDAQ:TMCI) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, community ranking, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.
Treace Medical Concepts received 22 more outperform votes than Nutriband when rated by MarketBeat users. However, 44.44% of users gave Nutriband an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote.
84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 19.7% of Nutriband shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 54.1% of Nutriband shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Treace Medical Concepts has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Nutriband has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.
Treace Medical Concepts has a net margin of -30.33% compared to Nutriband's net margin of -338.51%. Treace Medical Concepts' return on equity of -51.12% beat Nutriband's return on equity.
In the previous week, Treace Medical Concepts had 23 more articles in the media than Nutriband. MarketBeat recorded 31 mentions for Treace Medical Concepts and 8 mentions for Nutriband. Treace Medical Concepts' average media sentiment score of 0.12 beat Nutriband's score of 0.09 indicating that Treace Medical Concepts is being referred to more favorably in the media.
Treace Medical Concepts currently has a consensus price target of $10.16, suggesting a potential upside of 70.14%. Nutriband has a consensus price target of $13.00, suggesting a potential upside of 72.41%. Given Nutriband's stronger consensus rating and higher probable upside, analysts clearly believe Nutriband is more favorable than Treace Medical Concepts.
Nutriband has lower revenue, but higher earnings than Treace Medical Concepts. Nutriband is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.
Summary
Treace Medical Concepts beats Nutriband on 11 of the 18 factors compared between the two stocks.
Get Nutriband News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NTRB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nutriband Competitors List
Related Companies and Tools
This page (NASDAQ:NTRB) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy NTRB Stock Free NTRB Stock Alerts